Karthik Venkatakrishnan

Title: Karthik Venkatakrishnan: Innovator in Pharmaceutical Sciences

Introduction

Karthik Venkatakrishnan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in enhancing drug efficacy and treatment methodologies.

Latest Patents

Karthik holds 4 patents that reflect his innovative approach to drug development. His latest patents include a method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P450. This patent describes compositions comprising methyl 3-((methyl sulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof, along with an agent for reducing metabolism of the compound and its uses. Another significant patent involves methods of treating cancer in pediatric patients, specifically targeting cancers such as inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma using brigatinib, either as monotherapy or in combination with other therapeutic agents.

Career Highlights

Throughout his career, Karthik has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals Limited. His work has focused on developing innovative solutions to complex medical challenges.

Collaborations

Karthik has collaborated with esteemed colleagues, including Robert W Kleinfield and Kha N Le, to advance research and development in his field.

Conclusion

Karthik Venkatakrishnan's contributions to pharmaceutical sciences through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative methods and dedication to research continue to make a significant impact in the medical community.